Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 32208984)

  • 1. Sonication tailored enhance cytotoxicity of naringenin nanoparticle in pancreatic cancer: design, optimization, and
    Akhter MH; Kumar S; Nomani S
    Drug Dev Ind Pharm; 2020 Apr; 46(4):659-672. PubMed ID: 32208984
    [No Abstract]   [Full Text] [Related]  

  • 2. Brigatinib loaded poly(d,l-lactide-co-glycolide) nanoparticles for improved anti-tumoral activity against non-small cell lung cancer cell lines.
    Ahmed MM; Fatima F; Anwer MK; Aldawsari MF; Bhatia S; Al-Harrasi A
    Drug Dev Ind Pharm; 2021 Jul; 47(7):1112-1120. PubMed ID: 34551665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microfluidic fabrication and characterization of Sorafenib-loaded lipid-polymer hybrid nanoparticles for controlled drug delivery.
    Tahir N; Madni A; Li W; Correia A; Khan MM; Rahim MA; Santos HA
    Int J Pharm; 2020 May; 581():119275. PubMed ID: 32229283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carboplatin loaded Surface modified PLGA nanoparticles: Optimization, characterization, and in vivo brain targeting studies.
    Jose S; Juna BC; Cinu TA; Jyoti H; Aleykutty NA
    Colloids Surf B Biointerfaces; 2016 Jun; 142():307-314. PubMed ID: 26970818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-delivery of gemcitabine and simvastatin through PLGA polymeric nanoparticles for the treatment of pancreatic cancer: in-vitro characterization, cellular uptake, and pharmacokinetic studies.
    Jamil A; Aamir Mirza M; Anwer MK; Thakur PS; Alshahrani SM; Alshetaili AS; Telegaonkar S; Panda AK; Iqbal Z
    Drug Dev Ind Pharm; 2019 May; 45(5):745-753. PubMed ID: 30632800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and in vitro characterization of 9-nitrocamptothecin-loaded long circulating nanoparticles for delivery in cancer patients.
    Derakhshandeh K; Soheili M; Dadashzadeh S; Saghiri R
    Int J Nanomedicine; 2010 Aug; 5():463-71. PubMed ID: 20957168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation optimization of etoposide loaded PLGA nanoparticles by double factorial design and their evaluation.
    Yadav KS; Sawant KK
    Curr Drug Deliv; 2010 Jan; 7(1):51-64. PubMed ID: 20044908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of different molecular weight PLGA on flurbiprofen nanoparticles: formulation, characterization, cytotoxicity, and
    Öztürk AA; Yenilmez E; Şenel B; Kıyan HT; Güven UM
    Drug Dev Ind Pharm; 2020 Apr; 46(4):682-695. PubMed ID: 32281428
    [No Abstract]   [Full Text] [Related]  

  • 9. Enhanced cancer therapy with pH-dependent and aptamer functionalized doxorubicin loaded polymeric (poly D, L-lactic-co-glycolic acid) nanoparticles.
    Saravanakumar K; Hu X; Shanmugam S; Chelliah R; Sekar P; Oh DH; Vijayakumar S; Kathiresan K; Wang MH
    Arch Biochem Biophys; 2019 Aug; 671():143-151. PubMed ID: 31283911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PHBV/PLGA nanoparticles for enhanced delivery of 5-fluorouracil as promising treatment of colon cancer.
    Handali S; Moghimipour E; Rezaei M; Ramezani Z; Dorkoosh FA
    Pharm Dev Technol; 2020 Feb; 25(2):206-218. PubMed ID: 31648589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation development and in vitro evaluation of gentamicin sulfate-loaded PLGA nanoparticles based film for the treatment of surgical site infection by Box-Behnken design.
    Dhal C; Mishra R
    Drug Dev Ind Pharm; 2019 May; 45(5):805-818. PubMed ID: 30698993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Docetaxel-loaded polylactic acid-co-glycolic acid nanoparticles: formulation, physicochemical characterization and cytotoxicity studies.
    Pradhan R; Poudel BK; Ramasamy T; Choi HG; Yong CS; Kim JO
    J Nanosci Nanotechnol; 2013 Aug; 13(8):5948-56. PubMed ID: 23882865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and Evaluation of Irinotecan Poly(Lactic-co-Glycolic Acid) Nanoparticles for Enhanced Anti-tumor Therapy.
    Yang X; Yang Y; Jia Q; Hao Y; Liu J; Huang G
    AAPS PharmSciTech; 2019 Feb; 20(3):133. PubMed ID: 30820689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Formulation and process optimization of doxorubicin-loaded PLGA nanoparticles and its in vitro release].
    Li JL; Zheng CL; Liu JP; Zhu JB
    Yao Xue Xue Bao; 2013 May; 48(5):759-66. PubMed ID: 23888702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of bicalutamide-loaded PLGA nanoparticles: preparation, characterization and in-vitro evaluation for the treatment of prostate cancer.
    Ray S; Ghosh Ray S; Mandal S
    Artif Cells Nanomed Biotechnol; 2017 Aug; 45(5):944-954. PubMed ID: 27327352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Redox-Sensitive Poly(lactic-
    Dhamija P; Mehata AK; Tamang R; Bonlawar J; Vaishali ; Malik AK; Setia A; Kumar S; Challa RR; Koch B; Muthu MS
    Mol Pharm; 2024 Jun; 21(6):2713-2726. PubMed ID: 38706253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A potential in situ gel formulation loaded with novel fabricated poly(lactide-co-glycolide) nanoparticles for enhancing and sustaining the ophthalmic delivery of ketoconazole.
    Ahmed TA; Aljaeid BM
    Int J Nanomedicine; 2017; 12():1863-1875. PubMed ID: 28331311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of novel coumarin-triazole hybrids and first evaluation of the 4-phenyl substituted hybrid loaded PLGA nanoparticles delivery system to the anticancer activity.
    Arvas B; Ucar B; Acar T; Varli HS; Arvas MB; Aydogan F; Yolacan C
    Nanotechnology; 2024 May; 35(30):. PubMed ID: 38636487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HPMA-PLGA Based Nanoparticles for Effective In Vitro Delivery of Rifampicin.
    Rani S; Gothwal A; Pandey PK; Chauhan DS; Pachouri PK; Gupta UD; Gupta U
    Pharm Res; 2018 Dec; 36(1):19. PubMed ID: 30511238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and in vitro evaluation of meloxicam-loaded PLGA nanoparticles on HT-29 human colon adenocarcinoma cells.
    Şengel-Türk CT; Hasçiçek C; Dogan AL; Esendagli G; Guc D; Gönül N
    Drug Dev Ind Pharm; 2012 Sep; 38(9):1107-16. PubMed ID: 22348284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.